New York Life Investment Management’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.59M Buy
31,122
+4,185
+16% +$715K 0.05% 306
2025
Q4
$3.81M Sell
26,937
-781
-3% -$88.7K 0.03% 373
2025
Q3
$2.25M Sell
27,718
-374
-1% -$28.8K 0.02% 524
2025
Q2
$1.76M Sell
28,092
-184
-0.7% -$10.9K 0.02% 554
2025
Q1
$2.04M Buy
28,276
+114
+0.4% +$9.28K 0.02% 537
2024
Q4
$2.42M Sell
28,162
-2,044
-7% -$204K 0.02% 511
2024
Q3
$2.86M Buy
30,206
+12,340
+69% +$1.1M 0.03% 487
2024
Q2
$1.71M Buy
17,866
+188
+1% +$22.4K 0.02% 590
2024
Q1
$2.33M Sell
17,678
-620
-3% -$76.3K 0.02% 527
2023
Q4
$2.64M Buy
18,298
+105
+0.6% +$14.4K 0.03% 482
2023
Q3
$3.09M Sell
18,193
-108
-0.6% -$21.5K 0.03% 400
2023
Q2
$4.08M Sell
18,301
-70
-0.4% -$14.3K 0.04% 358
2023
Q1
$4.06M Buy
18,371
+2
+0% +$493 0.05% 356
2022
Q4
$3.98M Sell
18,369
-2
-0% -$533 0.05% 367
2022
Q3
$4.86M Sell
18,371
-98
-0.5% -$24.9K 0.06% 312
2022
Q2
$3.86M Buy
+18,469
New +$4.12M 0.04% 359

Other funds holding ALB

New York Life Investment Management's ALB Position: Q1 2026 in Review

New York Life Investment Management increased its Albemarle (ALB) stake by 16% in Q1 2026, buying an estimated $715K and bringing the position to 31,122 shares worth $5.59M. The position accounts for 0.05% of the portfolio, ranked #306.

New York Life Investment Management first reported a position in ALB in Q2 2022 and has held it in 16 quarters since. 984 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • New York Life Investment Management held 31,122 shares of Albemarle worth $5.59M as of Q1 2026.
  • New York Life Investment Management bought 4,185 Albemarle shares in Q1 2026, an estimated $715K.
  • Albemarle made up 0.05% of New York Life Investment Management's portfolio in Q1 2026, its #306 holding.
  • New York Life Investment Management first reported a position in Albemarle in Q2 2022 and has held it in 16 quarters since.
  • 984 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.